Paclitaxel Polymeric Micelles is named as a drug or biological intervention in 3 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Liu Huang (1), Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1) and Shaodong Hong (1). Registered phase: Phase 2. Conditions studied include Pancreatic Adenocarcinoma; Cholangiocarcinoma; Lung Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06199895 | Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer (ClinicalTrials.gov ↗) Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer |
Phase 2 | Recruiting |
| NCT07662746 | Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (ClinicalTrials.gov ↗) Head and Neck Cancer |
Phase 2 | Recruiting |
| NCT07819591 | Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLC (ClinicalTrials.gov ↗) SCLC, Recurrent |
Phase 2 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Pancreatic Adenocarcinoma | 1 |
| Cholangiocarcinoma | 1 |
| Lung Cancer | 1 |
| Stomach Cancer | 1 |
| Head and Neck Cancer | 1 |
| SCLC, Recurrent | 1 |
| Lead sponsor | Trials |
|---|---|
| Liu Huang | 1 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 1 |
| Shaodong Hong | 1 |
| Register | Paclitaxel Polymeric Micelles trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Paclitaxel Polymeric Micelles works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Paclitaxel Polymeric Micelles (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.